|
Volumn 30, Issue 2, 2006, Pages 177-183
|
Improving access to medicines among clients of remote area Aboriginal and Torres Strait Islander Health Services
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIASTHMATIC AGENT;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
ORAL ANTIDIABETIC AGENT;
ABORIGINE;
ARTICLE;
AUSTRALIA;
CASE STUDY;
CONSULTATION;
COST BENEFIT ANALYSIS;
DRUG USE;
GOVERNMENT;
HEALTH CARE ACCESS;
HEALTH CARE COST;
HEALTH CARE FINANCING;
HEALTH CARE NEED;
HEALTH CARE POLICY;
HEALTH PROGRAM;
HEALTH SERVICE;
HUMAN;
INDIGENOUS PEOPLE;
INFORMATION PROCESSING;
INTERVIEW;
LAW;
PHARMACIST;
PHARMACY;
PRIMARY MEDICAL CARE;
PRIMARY PREVENTION;
REIMBURSEMENT;
AUSTRALIA;
COMMUNITY PHARMACY SERVICES;
DRUG UTILIZATION REVIEW;
HEALTH CARE REFORM;
HEALTH SERVICES ACCESSIBILITY;
HEALTH SERVICES, INDIGENOUS;
HUMANS;
MODELS, ORGANIZATIONAL;
NATIONAL HEALTH PROGRAMS;
OCEANIC ANCESTRY GROUP;
ORGANIZATIONAL INNOVATION;
PATIENT COMPLIANCE;
PROGRAM EVALUATION;
RURAL HEALTH SERVICES;
|
EID: 33646244282
PISSN: 13260200
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1467-842X.2006.tb00113.x Document Type: Article |
Times cited : (20)
|
References (7)
|